Sumitomo Mitsui Trust provides Japanese equity products for corporate and governmental pension funds.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Sumitomo Mitsui Trust provides Japanese equity products for corporate and governmental pension funds. SMTB also provides products investing in Asian equities. The capability was developed through its experience in Japanese equity, although it maintains an investment team in Hong Kong.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
5/2021 | Axelspace | Series C | 0 |
10/2020 | KAKEHASHI | Venture Round | 17.1M |
3/2021 | CureApp | Series D | 0 |
9/2020 | Xica | Series D | 11.5M |
3/2017 | Croesus Retail Asset Management | Debt Financing | 27.1M |
7/2018 | Rapyuta Robotics | Series A | 9.5M |
3/2020 | Cogent Labs | Series C | 0 |
5/2021 | ThinkCyte | Series B | 0 |
3/2016 | Mercari | Series D | 74M |
10/2021 | Aculys Pharma | Series A | 0 |
11/2019 | Wealthnavi | Series D | 23.8M |
3/2022 | Synspective | Series B | 96.6M |
4/2001 | USEN | Private Equity Round | - |
12/2016 | Freee | Series D | 28.6M |
6/2023 | FLUX | Series B | 0 |
9/2019 | Global Mobility Service | Series D | 16M |
10/2020 | Visional | Venture Round | 0 |
9/2019 | Yoriso | Series D | 18.8M |
4/2021 | creww | Venture Round | - |
11/2017 | Sansan | Series D | 17.6M |
6/2021 | Heartseed | Series C | 37M |
3/2022 | Aculys Pharma | Series B | 0 |
8/2019 | DataX | Private Equity Round | 94.1M |
3/2016 | BizReach | Series A | 37.7M |
8/2015 | Freee | Series C | 30M |
7/2023 | CADDi | Series C | 0 |
3/2022 | Aculys Pharma | Series B | 0 |
10/2021 | Aculys Pharma | Series A | 0 |
6/2021 | Heartseed | Series C | 0 |
5/2021 | ThinkCyte | Series B | 0 |
5/2021 | Axelspace | Series C | 0 |
4/2021 | creww | Venture Round | - |
3/2021 | CureApp | Series D | 0 |
10/2020 | Visional | Venture Round | 0 |
10/2020 | KAKEHASHI | Venture Round | 0 |
9/2020 | Xica | Series D | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|